{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:07:53Z","timestamp":1784128073873,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jogc.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T15:49:26Z","timestamp":1495122566000},"page":"480-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian\/Fallopian Tube\/Peritoneal Cancer in the General Population"],"prefix":"10.1016","volume":"39","author":[{"given":"Shannon","family":"Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ann","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Giede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2016.12.005_bib1","series-title":"Canadian Cancer Statistics 2015","year":"2015"},{"key":"10.1016\/j.jogc.2016.12.005_bib2","series-title":"Canadian Cancer Statistics 2014","year":"2014"},{"key":"10.1016\/j.jogc.2016.12.005_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib4","series-title":"GOC Statement Regarding Salpingectomy and Ovarian Cancer Prevention","year":"2011"},{"key":"10.1016\/j.jogc.2016.12.005_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","article-title":"Committee opinion no. 620: salpingectomy for ovarian cancer prevention","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib6","series-title":"SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention","year":"2013"},{"key":"10.1016\/j.jogc.2016.12.005_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-015-3697-y","article-title":"Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO","volume":"292","author":"Polcher","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl 10","key":"10.1016\/j.jogc.2016.12.005_bib8","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib9","first-page":"740968","article-title":"Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma","volume":"2010","author":"Gilks","year":"2010","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib10","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S146239940800077X","article-title":"Critical molecular abnormalities in high-grade serous carcinoma of the ovary","volume":"10","author":"Kobel","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jogc.2016.12.005_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2012.03.006","article-title":"BRCA1\/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer","volume":"125","author":"Dann","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib13","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1200\/JCO.2009.27.2997","article-title":"Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer","volume":"28","author":"Hennessy","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/modpathol.2011.211","article-title":"BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma","volume":"25","author":"McAlpine","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.12.005_bib17","first-page":"711","article-title":"Determinants of ovarian cancer risk. I. Reproductive experiences and family history","volume":"71","author":"Cramer","year":"1983","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/ijc.22491","article-title":"Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975-2004","volume":"120","author":"Riska","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006254-196104000-00022","article-title":"Primary carcinoma of the fallopian tube","volume":"16","author":"Sedlis","year":"1961","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogc.2016.12.005_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006254-197904000-00001","article-title":"Carcinoma of the fallopian tube","volume":"34","author":"Yoonessi","year":"1979","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogc.2016.12.005_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004347-200104000-00003","article-title":"Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohistochemical case control study","volume":"20","author":"Demopoulos","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.12419","article-title":"Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal","volume":"65","author":"Singh","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.jogc.2016.12.005_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation","volume":"160","author":"Nelson","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogc.2016.12.005_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib29","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10689-004-9554-y","article-title":"Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations","volume":"3","author":"Casey","year":"2004","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","volume":"110","author":"Salvador","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PGP.0000000000000123","article-title":"Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer)","volume":"34","author":"Seidman","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib38","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A\u00a0candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Bahar-Shany","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jogc.2016.12.005_bib44","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/IGC.0000000000000379","article-title":"Fimbrial cells exposure to catalytic iron mimics carcinogenic changes","volume":"25","author":"Lattuada","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004347-200204000-00001","article-title":"Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?","volume":"21","author":"Seidman","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jogc.2016.12.005_bib47","doi-asserted-by":"crossref","first-page":"824627","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib48","doi-asserted-by":"crossref","first-page":"219672","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jogc.2016.12.005_bib50","first-page":"233","article-title":"Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review)","volume":"22","author":"Kobayashi","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jogc.2016.12.005_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan","volume":"17","author":"Kobayashi","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jmoldx.2015.01.006","article-title":"Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis","volume":"17","author":"Kocbek","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jogc.2016.12.005_bib53","first-page":"2197","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jogc.2016.12.005_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.26469","article-title":"Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study","volume":"131","author":"Yang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2016.12.005_bib57","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/ijc.28249","article-title":"Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England case-control study","volume":"133","author":"Rice","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2016.12.005_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-13-0515","article-title":"Dietary intake and ovarian cancer risk: a systematic review","volume":"23","author":"Crane","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jogc.2016.12.005_bib61","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2014.16","article-title":"Dietary fat intake and risk of epithelial ovarian cancer by tumour histology","volume":"110","author":"Merritt","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2013.03.016","article-title":"Preserved foods associated with increased risk of ovarian cancer","volume":"129","author":"Lee","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CEJ.0b013e328347622f","article-title":"Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study","volume":"21","author":"Aschebrook-Kilfoy","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jogc.2016.12.005_bib64","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2006.11.010","article-title":"Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis","volume":"43","author":"Olsen","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/ERC-12-0395","article-title":"Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium","volume":"20","author":"Olsen","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib66","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2013.03.003","article-title":"Nutritional status, CT body composition measures and survival in ovarian cancer","volume":"129","author":"Torres","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2014.10.011","article-title":"Old drug, new trick: repurposing metformin for gynecologic cancers?","volume":"135","author":"Febbraro","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/OGX.0000000000000092","article-title":"Metformin and gynecologic cancers","volume":"69","author":"Stine","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogc.2016.12.005_bib69","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/IGC.0b013e3182a80a21","article-title":"The effects of metformin on ovarian cancer: a systematic review","volume":"23","author":"Dilokthornsakul","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib70","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-13-0037","article-title":"Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls","volume":"6","author":"Terry","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jogc.2016.12.005_bib71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/CEJ.0b013e3283476242","article-title":"Perineal talc use and ovarian cancer risk: a case study of scientific standards in environmental epidemiology","volume":"20","author":"Huncharek","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jogc.2016.12.005_bib72","first-page":"106","article-title":"Talc use and ovarian cancer: epidemiology between a rock and a hard place","author":"Wentzensen","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib73","first-page":"106","article-title":"Perineal powder use and risk of ovarian cancer","author":"Houghton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib74","doi-asserted-by":"crossref","first-page":"djt453","DOI":"10.1093\/jnci\/djt453","article-title":"Aspirin in prevention of ovarian cancer: are we at the tipping point?","volume":"106","author":"Tsoref","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib75","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib76","doi-asserted-by":"crossref","first-page":"dju111","DOI":"10.1093\/jnci\/dju111","article-title":"Prescription use of paracetamol and risk for ovarian cancer in Denmark","volume":"106","author":"Baandrup","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib77","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2016.12.005_bib78","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.12.005_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2007.01035.x","article-title":"A\u00a0randomized study of screening for ovarian cancer: a multicenter study in Japan","volume":"18","author":"Kobayashi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/GCO.0000000000000060","article-title":"Use of fertility drugs and risk of ovarian cancer","volume":"26","author":"Diergaarde","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib81","first-page":"1660","article-title":"Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort","volume":"100","author":"Trabert","year":"2013"},{"key":"10.1016\/j.jogc.2016.12.005_bib82","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.fertnstert.2013.02.010","article-title":"Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study","volume":"99","author":"Asante","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2016.12.005_bib83","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In\u00a0vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2016.12.005_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/humupd\/dms051","article-title":"Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer\u2014a systematic review and meta-analysis","volume":"19","author":"Siristatidis","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2016.12.005_bib85","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","article-title":"New insights in the pathophysiology of ovarian cancer and implications for screening and prevention","volume":"213","author":"Nezhat","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/aogs.12123","article-title":"Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer","volume":"92","author":"Melin","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2016.12.005_bib87","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jmig.2015.04.012","article-title":"Success and complications of salpingectomy at the time of vaginal hysterectomy","volume":"22","author":"Robert","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib88","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jmig.2016.05.006","article-title":"Postpartum permanent sterilization: could bilateral salpingectomy replace bilateral tubal ligation?","volume":"23","author":"Danis","year":"2016","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib89","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmig.2015.02.013","article-title":"Surgical outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women","volume":"22","author":"Minig","year":"2015","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2016.12.005_bib90","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib91","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00432-014-1622-6","article-title":"Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate","volume":"140","author":"Vorwergk","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jogc.2016.12.005_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002845","article-title":"Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010","volume":"3","author":"Guldberg","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jogc.2016.12.005_bib93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogc.2016.12.005_bib94","first-page":"107","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","author":"Falconer","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2016.12.005_bib95","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J\u00a0Obstet Gynecol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316398991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316398991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:29:51Z","timestamp":1761665391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216316398991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1701216316398991"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2016.12.005","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian\/Fallopian Tube\/Peritoneal Cancer in the General Population","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}